Staff Spotlights

In the Zone: A day in the life of a pediatric cardiac surgeon

by Columbia Surgery on February 10, 2012

Emile Bacha, MD

Emile Bacha, MD

Interview with Emile Bacha, MD, Chief, Division of Cardiothoracic Surgery at NewYork-Presbyterian Hospital/Columbia University Medical Center

In this interview, Dr. Bacha, Chief of the Division of Cardiothoracic Surgery at NewYork-Presbyterian/Columbia, provides a glimpse into what it is like to perform open heart surgery on children every day, and what it takes to excel in such demanding circumstances. Having previously served as the director of pediatric heart surgery programs at Children’s Hospital in Boston and the University Hospitals of Chicago, Dr. Bacha has had many years of experience in learning how to be at one’s absolute best, day in and day out, when a child’s life is on the line.

Q: You describe something you consider indispensable to being a successful surgeon: the ability to be “in the zone,” as you put it. How would you describe being “in the zone?”

Dr. Bacha: Being “in the zone” means maintaining complete focus, concentration, and equanimity so that nothing distracts you from the task at hand. And this has to be done under any circumstance. It means being able to control your emotions so you can focus exclusively on the patient’s heart surgery. It means leaving your problems, whatever they may be — spousal, financial or whatever — at the door in the OR. It means not losing composure no matter what else may be going on.

Q: Why is this important?

Dr. Bacha: Being able to be “in the zone” really differentiates a successful surgeon from one who isn’t as successful. If you have a patient dying before your eyes, a limited time to do an operation, and the clock is ticking, are you able to hold it together and do the right thing? Or do you compensate by falling apart, or yelling or lashing out at your colleagues? In the field of pediatric cardiac surgery, emotions are especially magnified because we are dealing with a child’s life. Going through years of training is not enough; I have seen doctors who have had impeccable training and who are extremely ‘book-smart’ but who break down under pressure in the operating room. If you’re not able to control your emotions, you can’t function at a high level day after day after day.

I teach my residents that the tougher and the more acute it gets in the OR, the slower you should get. Because the adrenaline is flowing, you are usually not slower, but in fact achieve a sort of middle range where you are not hasty in your decisions and actions. Remember that a surgeon has to be physically proficient as well as intellectually. That is, you can be the smartest surgeon in the world, but if that stitch is not placed perfectly, the patient will die no matter how smart you are. Another thing I teach my residents is that the best teams handle emergencies in an orderly fashion, such that if an observer was watching the team work from the outside, he wouldn’t be able to tell that an emergency was going on.

Q: Was there ever a time you could not stay in the zone?

Dr. Bacha: A few years back, my wife and children got stuck in Lebanon in a war situation. They were at my mother’s house, and bombs were falling, and I was terribly worried. That was the one time I could not uncouple myself from what was going on, and I could not go into the operating room, and therefore canceled my cases.

Q: How do you maintain your equanimity – do you have any particular practices that help you stay balanced?

Dr. Bacha: I don’t meditate or do yoga or other practices in particular, no. I do have a stable family life, and I think that’s a big part of it. I think I am lucky because I have found it not too difficult to remain balanced. Other things are harder for me, but I grew up during the Lebanese civil war, with a lot of mayhem around me, so maybe I learned to have some innate order.

Related Link:
NewYork-Presbyterian/Columbia appoints Emile Bacha, MD, Chief of Cardiothoracic Surgery

{ 0 comments }

What is Acute Respiratory Distress Syndrome?

by Columbia Surgery on February 6, 2012

Drs. Daniel Brodie, left, and Matthew Bacchetta, right

Drs. Daniel Brodie, left, and Matthew Bacchetta, right

We all know what it’s like to bump an elbow or jam a finger and watch it swell up like rising dough. This swelling, due to increased fluid in the injured tissue, is part of the body’s attempt to promote healing. However, when it occurs in the lungs, it can have dangerous consequences.

Acute respiratory distress syndrome (ARDS) occurs when the millions of tiny air sacs in the lungs, called alveoli, fill with excess fluid. This can be the result of any kind of injury to or illness in the lung. Pneumonia, trauma, sepsis, and inhalation of stomach contents or smoke can all cause the body to initiate an inflammatory response, sending excess fluid to the lungs.

In healthy lungs, the alveoli fill with inhaled air, transferring oxygen into the blood carried by small neighboring vessels. The oxygen-rich blood can then travel throughout the body to deliver its cargo to the kidneys, brain, liver, and other organs. But when fluid accumulates in the alveoli, they can no longer fill with air, and oxygen cannot pass as easily into the blood. Soon after the initial injury or illness, blood oxygen levels decline, and breathing becomes fast and difficult as the body tries to compensate. There may also be signs, such as confusion or low blood pressure, that the vital organs aren’t getting enough oxygen. In some patients, the lung may try to heal itself, creating scar tissue that decreases the lung’s elasticity and makes it still harder to breathe. The majority of patients recover, but around 40% die in the setting of ARDS, says Daniel Brodie, MD, Director of the Medical ECMO Program at NewYork-Presbyterian Hospital/Columbia University Medical Center.

Treatment for ARDS aims to restore oxygen levels. This may be done with a mechanical ventilator, or through a process called extracorporeal membrane oxygenation (ECMO), in which the blood is removed from the body and oxygenated externally before it is returned. In November 2011, NewYork-Presbyterian Hospital/Columbia University Medical Center opened the Center for Acute Respiratory Failure, which specializes in ECMO. Accompanying the Center’s launch was an article on ECMO for ARDS in adults by the Center’s co-directors, Daniel Brodie, MD, and Matthew Bacchetta, MD, published in the New England Journal of Medicine.

The ECMO program’s innovative approach has been highly successful: every adult ECMO patient has recovered and is now thriving. Click here to read their stories.

{ 0 comments }

NewYork-Presbyterian Hospital has a distinguished track record for liver transplantation and features a team of world renowned leaders in the field. The Center for Liver Disease and Transplantation offers a seamless integration of medical, surgical, radiological, and support services — using both deceased and living donor liver tissue, and minimally invasive laparoscopic techniques whenever possible.

Founded in 1998, the Center for Liver Disease and Transplantation at NewYork-Presbyterian Hospital/Columbia University Medical Center is one of the first liver programs built from its inception as a multidisciplinary unit. As of July 2011, the Center had performed more than 1,400 liver transplants, including over 200 living donor transplants. NewYork-Presbyterian Hospital/Weill Cornell Medical Center’s strong hepatobiliary program was bolstered by the addition of adult liver transplantation to its services in 2010.

Together these programs provide compassionate, individualized care to a wide variety of patients, combining exceptional care with the most innovative approaches for expanding access to liver transplantation to reduce the mortality of patients on the waiting list.

Alyson Fox, MD, NewYork-Presbyterian/ Weill Cornell Medical Center

Alyson Fox, MD

Alyson Fox, MD

Dr. Alyson Fox earned her BA in Public Health at the Johns Hopkins University prior to attending the Mount Sinai School of Medicine. She completed her residency in Internal Medicine at NY Presbyterian Weill Cornell Medical Center, where she served as assistant chief resident. She completed her Gastroenterology fellowship at the University of Pennsylvania. While at Penn, she completed a Masters in Clinical Epidemiology and served as chief fellow. She completed her advanced fellowship training in Advanced Transplant Hepatology at the University of California, San Francisco and was named clinical fellow of the year by the department of medicine.

Dr. Fox’s clinical practice is focused on the management of patients with a variety of liver diseases including viral hepatitis, alcoholic and non alcoholic fatty liver diseases, inherited liver diseases and liver cancers. As a transplant hepatologist, she has advanced training in the management of end stage liver disease and caring for patients both pre and post liver transplantation. Her research area is focused on issues related to organ allocation and complications of portal hypertension.

Elizabeth Verna, MD, NewYork-Presbyterian/ Columbia University Medical Center

Dr. Elizabeth Verna

Elizabeth Verna, MD

Dr. Elizabeth Verna, Assistant Professor of Medicine, earned her BA in Biology at the University of Virginia prior to attending the Columbia University College of Physicians and Surgeons for medical school. She completed her Internal Medicine residency at Columbia Presbyterian Hospital and then served as a Chief Resident before remaining at Columbia for Gastroenterology and Advanced/Transplant Hepatology fellowships.

While in fellowship, she also completed a Masters in Biostatistics at the Columbia University Mailman School of Public Health.

Dr. Verna’s clinical practice includes the management of patients with a variety of liver diseases with a focus on viral hepatitis and liver transplantation as well as the new emerging therapies for hepatitis C. She treats patients with liver cancer, alcoholic and non-alcoholic fatty liver disease and metabolic liver diseases and has expertise in the management of end stage liver disease. She has an active research program with grant support for the study of hepatitis C in liver transplant recipients and will be actively involved in clinical trials for the treatment of hepatitis C in both the transplant and non-transplant settings.

Julia Wattacheril, MD, NewYork-Presbyterian/ Columbia University Medical Center

Julia Wattercheril, MD

Julia Wattacheril, MD

Dr. Julia Wattacheril graduated magna cum laude from Brandeis University in Waltham, Massachusetts, obtained her MD with high honors from Baylor College of Medicine, did her internal medicine training at the Baylor College of Medicine in Houston, Texas and pursued her fellowship in gastroenterology, hepatology and nutrition as well as her Masters in Public Health at Vanderbilt University School of Medicine. She joined us last year for her training in transplant hepatology while maintaining an adjunct faculty appointment at Vanderbilt.

Her clinical interests include all aspects of transplant hepatology, general hepatology and gastroenterology with emphasis on metabolic liver disease and obesity. She specializes in nonalcoholic fatty liver disease as well as all forms of hepatitis, chronic liver disease, and liver cancer in addition to liver transplantation. Her research interests focus on hepatic steatosis, insulin resistance and metabolic liver disease in adults. Her current grant concentrates on the proteins and lipids that signal the transition from steatosis to steatohepatitis.

{ 0 comments }

Challenges in Liver Transplantation: Allocation of Donor Organs

by Columbia Surgery on November 16, 2011

Robert S. Brown, Jr., MD, MPH

Robert S. Brown, Jr., MD, MPH

The November 10, 2011 issue of the New England Journal of Medicine features an editorial by Robert S. Brown, Jr., MD, MPH, Director of the Center for Liver Disease and Transplantation, titled Transplantation for Alcoholic Hepatitis — Time to Rethink the 6-Month “Rule.”

In this editorial, Dr. Brown addresses the difficult questions surrounding how to fairly allocate donor organs, which are in far shorter supply than their demand. In the case of patients with alcoholic hepatitis, current guidelines exclude such patients from the liver transplant waiting list unless they have successfully abstained from alcohol for at least six months. Yet as Dr. Brown points out, many die before this required, albeit arbitrary, window elapses. And a new study indicates that if they are permitted to receive liver transplants, such patients may do at least as as well as, if not better than, some other patients who receive transplants far more often.

As Dr. Brown explains in this editorial, the typical recidivism rate among alcoholics is approximately 30%. Yet organs are regularly allocated to patients with hepatitis C, who have a 100% disease recurrence rate, and a much higher rate of graft failure than those with alcoholic hepatitis, at five years. A study by Mathurin et al in this issue found that carefully selected patients with alcoholic hepatitis experienced a 77% survival rate after liver transplantation at six months, and a recidivism rate of 11.5%. Based on these encouraging results, Dr. Brown writes, “…this study highlights the need to rethink our approach to transplantation for alcoholic liver disease, including applying better rules for selecting patients who are at low risk for recidivism that can be applied in a uniform and fair way.”

{ 0 comments }

GLOW magazine’s Isabel Stoltzman has just published highly informative interviews with Sheldon Feldman, MD, Chief of the Breast Surgery Section, and Robert T. Grant, MD, Chief of the Division of Plastic Surgery, at NewYork-Presbyterian/Columbia.

In ‘The Silver Lining,’ Dr. Grant highlights the latest procedures available to women undergoing surgery for breast cancer, including nipple-sparing mastectomy and the multiple options for reconstruction of the breasts. He describes the ‘silver lining’ in undergoing cancer surgery – the opportunity to recreate breasts that are cosmetically as good as (or even better than!) they were before cancer.

In the second article titled ‘Breast Cancer,’ Dr. Feldman discusses the current state of the field of breast cancer detection and treatment. He describes some of the cutting edge research now underway, such efforts to develop a test for breast cancer involving nothing more than a simple, non-invasive PAP smear of the breast. These and many other research projects of Dr. Feldman’s are discussed in detail in the article.

Together, Dr. Feldman and Dr. Grant address the history of breast cancer treatment, comparing the routine mastectomies of the past with the way recent research allows each patient to receive fully customized care, with a treatment plan that takes into account the stage, size, and location of her specific form of cancer, among other things. They discuss some of the complexities of treating patients who want to have their breasts entirely removed even when it might not be advisable, and, Dr. Feldman summarizes the prevailing thought and research regarding the prevention of breast cancer.

In addition to this objectively useful information, we are also given a moving glimpse of the tragic personal influences that eventually led Dr. Feldman to specialize in breast surgery. “I always say I didn’t choose this specialty – it chose me,” he says. To find out more read the full articles in the Fall 2011 issue of GLOW magazine.

Glow Magazine Fall 2011

Glow Magazine Fall 2011

{ 0 comments }

The History of the Columbia University Department of Surgery

by Columbia Surgery on October 27, 2011

Through a lecture to the Physicians and Surgeons (P&S) Whipple Society, Kenneth A. Forde, M.D., Jose M. Ferrer Professor Emeritus at Columbia University’s College of Physicians and Surgeons, shares his enthusiasm for the remarkable history of Columbia University’s Department of Surgery. He discusses the challenges faced and the changes that have occurred in the over 230 years of the department’s existence, bringing to life the many inspirational figures that make up the department’s storied past.

  • There is Dr. Virginia Apgar, for instance, creator of the famous Apgar score used to quickly assess the health of newborn children;
  • Dr. Keith Reemtsma, who led the department into the field of transplantation;
  • Dr. Charles Fox, who developed in 1962 the antimicrobial agent silver sulfadiazine, which is still used worldwide to treat second- and third-degree burns;
  • Dr. Allen Whipple himself, of course, who oversaw and encouraged many of the school’s boldest changes in both clinical research and surgical practice; and many, many others.

Dr. Forde’s engaging, informative history helps us appreciate the generations of work and passion that have made the College of Physicians and Surgeons the world-class institution it is today.

{ 0 comments }

Bonnie Badenchini

Bonnie Badenchini

The Pancreas Center will hold its Annual Pancreatic Cancer Awareness Day Saturday, November 12, 2011 at the Vivian and Seymour Milstein Family Heart Center. At this free event, experts from NewYork-Presbyterian Hospital, Columbia University Medical Center, The Pancreas Center, and The Muzzi Mirza Pancreatic Cancer Prevention & Genetics Program will provide a free patient education program about screening and early detection of pancreatic cancer.

In the following interview, Bonnie Badenchini, Coordinator for the Pancreas Center, explains the history behind this event.

Question: When was the first NYP/Columbia Pancreatic Cancer Awareness Day held? Why did the doctors and staff decide that an event like this was needed?

Bonnie: The initial group of doctors that would later form The Pancreas Center came together in the mid-1990′s. The medical field was starting to realize that pancreatic cancer required a multi-disciplinary approach that included interventional gastroenterologists, oncologists, and surgical specialists. In 2005, our group at NewYork-Presbyterian/Columbia was officially launched as The Pancreas Center.

Dr. John Chabot felt that a forum was needed where findings, new research, and our innovative approaches could be communicated to other NYP/Columbia doctors and the community at large. This meeting could also provide patients and their families an opportunity to speak with Pancreas Center doctors outside the confines of a medical office. So from that need, the first Pancreatic Cancer Awareness Day was planned.

Question: How has Pancreatic Cancer Awareness Day changed over time?

Bonnie: As can be the case with first-year events, it was difficult to get the word out for our first event and attendance was low. But we believed in the purpose and necessity of this event and have proudly watched it grow in attendance to 125 in 2010.

Another important and more exciting difference is our agenda of topics. Today, there are more research studies and clinical trials to discuss. Since our center’s formation we’ve started to address pancreatic cancer prevention and screening techniques, and can provide attendees with the news on our findings in those areas.

We will also discuss the addition to the Pancreatic Cyst Surveillance Program headed by Dr. John Allendorf. With this program we are establishing methods to monitor pancreatic cysts that could potentially turn into cancer.

Question: What differences will attendees see this year compared to last year’s event?

Bonnie: For the first time this year we are going to have a patient speaker. We believe that others who have been touched by this disease will draw strength and support by hearing from a peer. As Dr. Chabot has said, “All a patient with pancreatic cancer and their family have is hope.” Our goal is to provide as much hope as it takes to inspire patients to push through, families to stay strong, and physicians to keep looking for a cure.

Question: What was one of your most inspiring moments at a Pancreatic Cancer Awareness Day?

Bonnie: Every Awareness Day inspires me. I have been with the Pancreas Center from the beginning and have watched this center grow and achieve goals that have affected so many lives. What has touched me the most has not only been the growth in attendees but the increase in number of survivors.

Question: Pancreatic cancer has been in the news recently with the stories of Steve Jobs, Pavarotti and Patrick Swayze. Do you think this is making a big difference in the general public’s awareness of pancreatic cancer?

Bonnie: I do believe this does makes a difference. If the passing of a celebrity from pancreatic cancer helps to make people more aware of it, and they take steps to obtain screening for themselves or loved ones, then some positive effect has happened.

Question: Will those who cannot attend the Pancreatic Cancer Awareness Day be able to see copies of the presentations?

Bonnie: Yes, we will put these on our web site www.pancreascenter.org and post them to our Facebook page at www.facebook.com/pancreascenter. The best thing to do is to “like” our Facebook page. Then our messages will appear on readers’ walls when they are posted.

Question: Is there anything else about the services and facilities within the Pancreas Center that you would like to share?

Bonnie: At the Pancreas Center we know all too well that being diagnosed with pancreatic cancer is devastating for patients as well as their families. We do everything possible to provide the best care for everyone involved with the diagnosis. The staff, nurses, and doctors all work tirelessly to help patients not just survive, but maintain as full and vibrant a life as possible. Meanwhile we continue to strive for the ultimate goal of finding a cure for this disease.

For more information on the Pancreatic Cancer Awareness Day and to register, please visit our Annual Pancreatic Cancer Awareness Day event page. Free parking is available and should be requested at the time of registration.


Interview by Bradley Jobling

{ 4 comments }

Columbia Physicians Help Train Surgeons in Western Africa

by Columbia Surgery on September 23, 2011

Surgeons OverSeas

Two surgeons from NYP/Columbia recently returned from a trip to Dakar, Senegal, where they met with surgeons from Liberia and Sierra Leone. Mark Hardy, MD, FACS worked alongside Adam Kushner, MD, MPH as part of the international humanitarian cooperation between Surgeons OverSeas (SOS) and the Education Leaders of the West African Surgical Society. Together, the American and African surgeons discussed the conditions and logistics needed to establish surgical residency programs in Monrovia, Liberia, and Freetown, Sierra Leone. They identified surgical residency goals and objectives for the present and the future.

Surgeons OverSeas is a program of the Society of International Humanitarian Surgeons devoted to improving basic surgical care in developing countries. The mission is not simply to provide surgical services, but to teach local doctors how to organize their surgical services and how to utilize modern surgical approaches whenever possible. It also helps to organize teaching of local staff and medical students. SOS was founded in 2007 when it was recognized that many public health initiatives, such as Doctors Without Borders, underemphasize the importance of surgical training, and that countless lives could be saved if only local doctors had the advantage of learning basic surgical skills and how to apply them in urgent situations. To this end, Drs. Hardy and Kushner have been working to establish new surgical residency programs in Liberia and Sierra Leone.

The reach of Surgeons OverSeas is not limited to western Africa. The organization has about 170 surgeons working across more than 20 countries, including many in Asia, Central America, South America, Europe, and the Middle East. Their efforts are funded partly by the NIH, but much of their resources come from the generosity of friends and family.

Prof Mark Hardy Discussing Development of Surgical Residency Training with Surgeons from Sierra Leone at WACS meeting Dakar Senegal

Prof Mark Hardy Discussing Development of Surgical Residency Training with Surgeons from Sierra Leone at WACS meeting in Dakar Senegal

Check out the new photos uploaded by Dr. Kushner on the Surgeon OverSeas Facebook page.

Adam Kushner, MD, MPH, FACS, is Lecturer in Surgery at Columbia University College of Physicians and Surgeons and Founder of SOS (Surgeons OverSeas). Mark Hardy, MD, FACS, is Auchincloss Professor of Surgery at Columbia University College of Physicians and Surgeons and Director Emeritus/Founder of Organ Transplantation at NewYork-Presbyterian Hospital/Columbia University Medical Center. Dr. Kushner is on the Board of Directors of Surgeons OverSeas, and has is now back in Sierra Leone; Dr. Hardy is on the Board of Advisors of SOS, and makes similar trips when necessary.

{ 0 comments }

John Chabot, MD, Named Vice President of ColumbiaDoctors

by Columbia Surgery on September 14, 2011

John A. Chabot, MD, was named Vice President of ColumbiaDoctors, the physician practice organization at Columbia University Medical Center.

John Chabot, MD, FACS

John Chabot, MD, FACS

Dr. Chabot has spent the duration of his career at NewYork-Presbyterian/Columbia since 1983, when he began his internship in transplantation. He has dedicated his career with resolute focus on the prevention, treatment, and cure for pancreatic cancer. Having progressed from intern, resident, and fellow to Professor, mentor, and Executive Director of the Pancreas Center at NewYork-Presbyterian/Columbia, Dr. Chabot intimately understands the culture and practice of medicine and surgery at the hospital. He is in a well-grounded position to lead ColumbiaDoctors in responding to the challenges associated with rapid innovation, advancing technology, and the highly informed patient.

In addition to serving as Executive Director of the Pancreas Center, Dr. Chabot is Chief of GI/Endocrine Surgery at NewYork-Presbyterian Hospital and the David V. Habif Professor of Surgery at Columbia University College of Physicians and Surgeons.

{ 5 comments }

This summer, Kenneth P. Olive, PhD traveled to Washington DC to ask members of Congress to pass the Pancreatic Cancer Research and Education Act. He was joined by Gloria H. Su, PhD, NewYork-Presbyterian/Columbia patient-activist Ralph Cheney, as well as 550 patients, family members, and advocates from all 50 states, as a part of the annual Pancreatic Cancer Action Network Advocacy Day.

This legislation, if passed, would direct the National Cancer Institute (NCI) to develop a strategic plan to combat pancreatic cancer. Because overall survival rates against pancreatic cancer have scarcely improved in the past 40 years, Dr. Olive and the Pancreatic Cancer Action Network believe it is extremely urgent that an organized plan of attack be enacted to enable new approaches to fighting this disease.

Since surviving a pancreatic cancer diagnosis while being treated by the Pancreas Center at NYP/Columbia, Ralph Cheney and his wife have devoted themselves to making sure that the Pancreatic Cancer Research and Education Act is passed. Mariann Cheney explains that at this time, there is a version of the bill both in the House and the Senate. With enough support, these bills may pass, providing cancer researchers like Dr. Olive and Dr. Su with the opportunity to continue doing their important work.

{ 0 comments }